The American College of Cardiology issued new guidance Tuesday that recommends adults with heart disease get vaccinated against respiratory illnesses, including RSV, COVID-19, pneumococcal infection, shingles and influenza. https://t.co/iBBHSZmuda
“In the year preceding the introduction of RSV vaccination in the US, RSV was associated with a substantial burden of adult hospitalizations, especially among adults ≥ 60 years old, underscoring the potential benefits of RSV vaccination in older adults” https://t.co/zh1fX72Lfm
“ACC released vaccination recommendations for adults with cardiovascular disease, urging immunization against COVID-19, influenza, respiratory syncytial virus (RSV), pneumonia, and herpes zoster” https://t.co/ysVesGIB1G
The American College of Cardiology (ACC) has issued new guidance recommending that adults with cardiovascular disease receive vaccinations against five respiratory illnesses: COVID-19, influenza, respiratory syncytial virus (RSV), pneumococcal infection, and shingles. This recommendation follows research highlighting the substantial burden of RSV-related hospitalizations among older adults in the United States, particularly those aged 60 and above, prior to the availability of an RSV vaccine. Additionally, infants younger than six months are reported to be at three times higher risk of hospitalization from severe RSV compared to human metapneumovirus (HMPV). In a related development, the American College of Obstetricians and Gynecologists (ACOG) has diverged from CDC guidance by recommending maternal vaccination against COVID-19, encouraging all pregnant women, those trying to conceive, and nursing mothers to receive an updated COVID-19 vaccine. These developments underscore a growing emphasis on vaccination to protect vulnerable populations from respiratory illnesses.